Comparison of Repeated Doses of Ivermectin Versus Ivermectin Plus Albendazole for the Treatment of Onchocerciasis: A Randomized, Open-label, Clinical Trial

BACKGROUND: Improved treatment for onchocerciasis is needed to accelerate onchocerciasis elimination in Africa. Aiming to better exploit registered drugs, this study was undertaken to determine whether annual or semiannual treatment with ivermectin (IVM; 200 µg/kg) plus albendazole (ALB; 800 mg sing...

Descripción completa

Detalles Bibliográficos
Autores principales: Batsa Debrah, Linda, Klarmann-Schulz, Ute, Osei-Mensah, Jubin, Dubben, Bettina, Fischer, Kerstin, Mubarik, Yusif, Ayisi-Boateng, Nana Kwame, Ricchiuto, Arcangelo, Fimmers, Rolf, Konadu, Peter, Nadal, Jennifer, Gruetzmacher, Barbara, Weil, Gary, Kazura, James W, King, Christopher L, Debrah, Alexander Y, Hoerauf, Achim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Articles and Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7428389/
https://www.ncbi.nlm.nih.gov/pubmed/31536624
http://dx.doi.org/10.1093/cid/ciz889

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7428389/
https://www.ncbi.nlm.nih.gov/pubmed/31536624
http://dx.doi.org/10.1093/cid/ciz889

Ejemplares similares